Hana Pharm Co., Ltd. (KRX:293480)
10,540
-210 (-1.95%)
At close: Jan 9, 2026
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 187.33 billion as of January 9, 2026. Its market cap has increased by 0.38% in one year.
Market Cap
187.33B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
4.70
Stock Price
10,540.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 187.33B, a decrease of -65.12%. That is a compound annual growth rate of -13.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 187.33B | -6.06% |
| Dec 30, 2025 | 199.41B | 2.94% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |